Vitalea Science is a GLP compliant facility and is the first U.S.-based bioanalytical contract research organization dedicated to providing services for exploring the pharmacokinetics and metabolism of drug candidates directly in humans. Headquartered in Davis, California, Vitalea offers the BioMICADAS AMS platform, the only AMS instrument purpose-built, in collaboration with the Swiss Federal Institute of Technology, to address the specific needs of the pharmaceutical industry.
Accium BioSciences is a provider of GLP-compliant accelerator mass spectrometry (AMS) services to the global pharmaceutical and life science industries. Based in Seattle, Washington, Accium operates a National Electrostatics Model 1.5SDH-1 Pelletron Accelerator, a dual acceleration (tandem) electrostatic accelerator. Accium’s customers use AMS to obtain critical information in pharmacokinetics, metabolism, absolute bioavailability and mass balance.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/3/prweb9259681.htm